14882-18-9 | Bismuth Subsalicylate

Packsize	Purity	Availability	Price	Discounted Price
25g	98%	in stock	$11.00	$8.00
500g	98%	in stock	$80.00	$56.00

Description

• Catalog Number: AA73964
• Chemical Name: Bismuth Subsalicylate
• CAS Number: 14882-18-9
• Molecular Formula: C7H5BiO4
• Molecular Weight: 362.0926
• MDL Number: MFCD00085368
• SMILES: O[Bi]1OC(=O)c2c(O1)cccc2
• NSC Number: 759117

Computed Properties

• Complexity: 173
• Covalently-Bonded Unit Count: 2
• Heavy Atom Count: 12
• Hydrogen Bond Acceptor Count: 4
• Hydrogen Bond Donor Count: 1

Literature

• Comparison of bismuth-containing quadruple and concomitant therapies as a first-line treatment option for Helicobacter pylori.

  The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20120201

• Mechanosynthesis of the metallodrug bismuth subsalicylate from Bi2O3 and structure of bismuth salicylate without auxiliary organic ligands.

  Angewandte Chemie (International ed. in English) 20110816

• Diagnosis and treatment of Helicobacter pylori infection.

  Danish medical bulletin 20110401

• Helicobacter pylori infection.

  The New England journal of medicine 20100805

• Crohn's colitis with perianal disease complicated by collagenous colitis: discourse on management options.

  Digestion 20100101

• Mucosal tear in collagenous colitis.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20090901

• Fluorescence in situ hybridization confirms clearance of visible Helicobacter spp. associated with gastritis in dogs and cats.

  Journal of veterinary internal medicine 20090101

• Expert review of the evidence base for self-therapy of travelers' diarrhea.

  Journal of travel medicine 20090101

• [Topic: Treating travelers' diarrhea. When should medication be given?].

  Der Urologe. Ausg. A 20080601

• Interventions for treating lymphocytic colitis.

  The Cochrane database of systematic reviews 20080416

• [Treating travelers' diarrhea. When should medication be given?].

  Der Internist 20071201

• Effect of smoking on failure of H. pylori therapy and gastric histology in a high gastric cancer risk area of Colombia.

  Acta gastroenterologica Latinoamericana 20071201

• Cooperative influence of thiolate ligands on the bio-relevant coordination chemistry of bismuth.

  Journal of inorganic biochemistry 20070401

• Pharmacotherapy for microscopic colitis.

  Pharmacotherapy 20070301

• Helicobacter pylori infection and thrombocytopenia: a single-institution experience in Mexico.

  Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 20070101

• Triple antimicrobial therapy and acid suppression in dogs with chronic vomiting and gastric Helicobacter spp.

  Journal of veterinary internal medicine 20070101

• Efficacy of two triple eradication regimens in children with Helicobacter pylori infection.

  Journal of Korean medical science 20061201

• Current and future developments in travelers' diarrhea therapy.

  Expert review of anti-infective therapy 20060601

• Salicylate toxicity associated with administration of Percy medicine in an infant.

  Pharmacotherapy 20060301

• [Plant sulfate assimilation and regulation of the activity of related enzymes under cadmium stress].

  Zhi wu sheng li yu fen zi sheng wu xue xue bao = Journal of plant physiology and molecular biology 20060201

• Travellers' diarrhoea: contemporary approaches to therapy and prevention.

  Drugs 20060101

• Copolymerizations of epsilon-caprolactone and glycolide-a comparison of tin(II)octanoate and bismuth(III)subsalicylate as initiators.

  Biomacromolecules 20050101

• Eradication of Helicobacter pylori can be accurately confirmed 14 days after termination of triple therapy using a high-dose citric acid-based 13C urea breath test.

  Digestion 20050101

• Interventions for treating collagenous colitis: a Cochrane Inflammatory Bowel Disease Group systematic review of randomized trials.

  The American journal of gastroenterology 20041201

• Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20040601

• Diagnosis and management of microscopic colitis syndrome.

  Journal of clinical gastroenterology 20040101

• One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection.

  Archives of internal medicine 20030922

• [Treatment of collagenous colitis. An analysis of a systematic Cochrane review].

  Ugeskrift for laeger 20030811

• Increased reflux symptoms after calcium carbonate supplementation and successful anti-Helicobacter pylori treatment.

  Digestive diseases and sciences 20030801

• Lymphocytic and collagenous colitis: the emerging entity of microscopic colitis. An update on pathophysiology, diagnosis and management.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20030701

• Interventions for treating collagenous colitis.

  The Cochrane database of systematic reviews 20030101

• Towards a molecular model for bismuth(III) subsalicylate. Synthesis and solid-state structure of [Bi(Hsal)3(bipy)(C7H8]2 and [Bi(Hsal)(sal)(1,10-phenanthroline)(C7H8]2.

  Chemical communications (Cambridge, England) 20021207

• Helicobacter pylori infection.

  The New England journal of medicine 20021010

• [Classic triple therapy for Helicobacter pylori infection].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Treatment of gastritis-associated Helicobacter pylori infection in children].

  Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru 20020101

• Interventions for treating collagenous colitis.

  The Cochrane database of systematic reviews 20020101

• Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage.

  Alimentary pharmacology & therapeutics 20011201

• Anti-inflammatory and tissue-protectant drug effects: results from a randomized placebo-controlled trial of gastritis patients at high risk for gastric cancer.

  Alimentary pharmacology & therapeutics 20010601

• Nitrofurantoin quadruple therapy for Helicobacter pylori infection: effect of metronidazole resistance.

  Alimentary pharmacology & therapeutics 20010401

• [Common gastrointestinal symptoms and their effective and safe treatment].

  Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti 19990501

• Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.

  The American journal of gastroenterology 19970901

• Bismuth subsalicylate prophylaxis of Cryptosporidium parvum infection in immunodeficient mice.

  The Journal of eukaryotic microbiology 19960101

• Protective effect of Pepto-Bismol liquid on the gastric mucosa of rats.

  Gastroenterology 19750901